Advertisement

  • Loading metrics

Open Access

Correction

Correction: EBV-miR-BART1-5P activates AMPK/mTOR/HIF1 pathway via a PTEN independent manner to promote glycolysis and angiogenesis in nasopharyngeal carcinoma

  • Xiaoming Lyu,
  • Jianguo Wang,
  • Xia Guo,
  • Gongfa Wu,
  • Yang Jiao,
  • Oluwasijibomi Damola Faleti,
  • Pengfei Liu,
  • Tielian Liu,
  • Yufei Long,
  • Tuotuo Chong,
  • Xu Yang,
  • Jing Huang,
  • Mingliang He,
  • Chi Man Tsang,
  • Sai Wah Tsao,
  • Qian Wang,
  • Qiang Jiang,
  •  [ ... ],
  • Xin Li
  • [ view all ]
  • [ view less ]
  • Article
  • Metrics
  • Comments
  • Media Coverage

The following information is missing from the Funding statement: This work was also supported by the Shenzhen Key Laboratory of Viral Oncology (ZDSYS201707311140430).

Reference

  1. 1. Lyu X, Wang J, Guo X, Wu G, Jiao Y, Faleti OD, et al. (2018) EBV-miR-BART1-5P activates AMPK/mTOR/HIF1 pathway via a PTEN independent manner to promote glycolysis and angiogenesis in nasopharyngeal carcinoma. PLoS Pathog 14(12): e1007484. https://doi.org/10.1371/journal.ppat.1007484 pmid:30557400

Citation: Lyu X, Wang J, Guo X, Wu G, Jiao Y, Faleti OD, et al. (2020) Correction: EBV-miR-BART1-5P activates AMPK/mTOR/HIF1 pathway via a PTEN independent manner to promote glycolysis and angiogenesis in nasopharyngeal carcinoma. PLoS Pathog 16(4): e1008532. https://doi.org/10.1371/journal.ppat.1008532

Published: April 27, 2020

Copyright: © 2020 Lyu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.